{
  "id": 14981553,
  "title": "FDA considers interim access for compounded peptides; Enspryng's label expansion",
  "url": "https://urgent.news/2026/10/16/fda-considers-interim-access-for-compounded-peptides-enspryngs-label",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-16T15:23:34.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/fda-considers-interim-access-for-compounded-peptides-enspryngs-label-expansion/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Microbiotica, Cyrano Therapeutics and Opus Genetics. HHS and FDA submit peptide policy for review: An “interim access policy for compounding using certain peptides” is awaiting regulatory review at the White House Office ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}